Ibrexafungerp Tablets Shortage
Last Updated: March 3, 2025
Status: Current
Products Affected - Description
-
- Brexafemme oral tablet, Scynexis, 150 mg, unit-dose blister pack, 4 count, NDC 75788-0115-04
Reason for the Shortage
-
- Scynexis recalled Brexafemme tablets in September 2023 due to a potential for cross-contamination. Additional information about the recall can be found at https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/scynexis-issues-voluntary-nationwide-recall-brexafemmer-ibrexafungerp-tablets-due-potential-cross#:~:text=The%20affected%20BREXAFEMME%C2%AE%20lots,US%2C%20beginning%20in%20December%202022.
Available Products
-
- There are no presentations available
Estimated Resupply Dates
-
- Scynexis has Brexafemme temporarily unavailable and the company cannot estimate when the product will return to the market.
Updated
Updated March 3, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 3, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.